<code id='E208617AE2'></code><style id='E208617AE2'></style>
    • <acronym id='E208617AE2'></acronym>
      <center id='E208617AE2'><center id='E208617AE2'><tfoot id='E208617AE2'></tfoot></center><abbr id='E208617AE2'><dir id='E208617AE2'><tfoot id='E208617AE2'></tfoot><noframes id='E208617AE2'>

    • <optgroup id='E208617AE2'><strike id='E208617AE2'><sup id='E208617AE2'></sup></strike><code id='E208617AE2'></code></optgroup>
        1. <b id='E208617AE2'><label id='E208617AE2'><select id='E208617AE2'><dt id='E208617AE2'><span id='E208617AE2'></span></dt></select></label></b><u id='E208617AE2'></u>
          <i id='E208617AE2'><strike id='E208617AE2'><tt id='E208617AE2'><pre id='E208617AE2'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:3
          Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT
          Adobe

          Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

          The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

          advertisement

          The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Wegovy trial has doctors encouraged over new possibilities
          Wegovy trial has doctors encouraged over new possibilities

          AdobeThemomentumaroundweightlossdrugsisabouttogetevenbiggerinthewakeofNovoNordisk’sannouncementthati

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          How to use technology to prevent future drug shortages

          TherehasbeenapersistentshortageoftheADHDdrugAdderall.JennyKane/APMyfirstexposuretopharmaceuticalshor